Yvette Bordelon, M.D., Ph.D.

Work Titles
UCLA Assistant Professor, Neurology Member, Brain Research Institute Member, Center for Neurodegenerative Disease Studies
M.D., University of Pennsylvania School of Medicine, 1999
Massachusetts General and Brigham and Women's Hospitals Neurology Residency Program
American Board of Psychiatry and Neurology
2005 American Board of Psychiatry and Neurology

Contact Information:

Email Address:




Work Phone Number:

(310) 794-1195


Office Address:

A-149 RNRC
710 Westwood Plaza
Los Angeles, CA 90095

Detailed Biography:

Dr. Bordelon received her MD and PhD degrees from the University of Pennsylvania. Her thesis work was performed with Dr. Marie-Francoise Chesselet and involved investigating mechanisms of cell death in an animal model of Huntington disease. She went on to residency training at Massachusetts General and Brigham and Women���s Hospitals and then did a Movement Disorders Fellowship at Columbia University before joining the Neurology faculty at UCLA in 2004. Her clinical work involves the diagnosis and treatment of Movement Disorders and her clinical research interests include clinical trials and development of biomarkers of disease in this subspecialty.


  Add here . . , , ; .
O'Duffy, A. E. Bordelon, Y. M. McLaughlin, B.   Killer proteases and little strokes--how the things that do not kill you make you stronger J Cereb Blood Flow Metab, 2007; 27(4): 655-68.
Bartzokis, G Lu, PH Tishler, TA Fong, SM Oluwadara, B Finn, JP Huang, D Bordelon, Y Mintz, J Perlman, S   Myelin Breakdown and Iron Changes in Huntington's Disease: Pathogenesis and Treatment Implications Neurochem Res, 2007; .
Frucht, SJ Houghton, WC Bordelon, Y Greene, PE Louis, ED   A single-blind, open-label trial of sodium oxybate for myoclonus and essential tremor Neurology, 2005; 65(12): 1967-9.
Frucht, SJ Bordelon, Y Houghton, WH Reardan, D   A pilot tolerability and efficacy trial of sodium oxybate in ethanol-responsive movement disorders Movement disorders : official journal of the Movement Disorder Society, 2005; 20(10): 1330-7.
Frucht, SJ Bordelon, Y Houghton, WH   Marked amelioration of alcohol-responsive posthypoxic myoclonus by gamma-hydroxybutyric acid (Xyrem) Movement disorders : official journal of the Movement Disorder Society, 2005; 20(6): 745-51.
Bordelon, YM Mackenzie, L Chesselet, MF   Morphology and compartmental location of cells exhibiting DNA damage after quinolinic acid injections into rat striatum The Journal of comparative neurology, 1999; 412(1): 38-50.
Bordelon, YM Chesselet, MF Ereci????ska, M Silver, IA   Effects of intrastriatal injection of quinolinic acid on electrical activity and extracellular ion concentrations in rat striatum in vivo Neuroscience, 1998; 83(2): 459-69.
Bordelon, YM Chesselet, MF Nelson, D Welsh, F Erecinska, M   Energetic dysfunction in quinolinic acid-lesioned rat striatum Journal of neurochemistry, 1997; 69(4): 1629-39.
Gurevich, EV Bordelon, Y Shapiro, RM Arnold, SE Gur, RE Joyce, JN   Mesolimbic dopamine D3 receptors and use of antipsychotics in patients with schizophrenia. A postmortem study Archives of general psychiatry, 1997; 54(3): 225-32.

Does this profile need updating? Contact Us